Nigeria spends approximately $150 million annually on vaccine procurement, the National Primary Health Care Development Agency (NPHCDA) has disclosed, underscoring the scale of investment required to sustain immunisation programmes nationwide.
The agency’s Executive Director, Muyi Aina, made the disclosure during the first quarterly media briefing of 2026 in Abuja, noting that funding is sourced from both government allocations and international partners such as Gavi, the Vaccine Alliance.
He, however, warned that global donor support is gradually declining, placing greater responsibility on Nigeria to increase domestic financing for vaccines and related healthcare services.
According to the agency, vaccine spending goes beyond procurement to include logistics such as syringes, cold chain systems, waste management, and operational costs tied to nationwide immunisation delivery.
Also Read: Tinubu Sacks Finance Minister Wale Edun, Installs Taiwo Oyedele as Replacement
The disclosure comes as Nigeria expands its malaria vaccination programme from initial pilot states to additional regions, including Bauchi and Ondo, in a bid to tackle one of the country’s most persistent public health challenges.
Health officials also noted that while vaccines remain among the most effective and cost-efficient medical interventions, ensuring full compliance particularly with multi-dose vaccines like the malaria shot remains a challenge.
The NPHCDA emphasized the need for sustained public trust and improved tracking systems to ensure higher vaccination coverage, especially among children.
The development highlights the growing financial burden of healthcare delivery in Nigeria and the urgent need for sustainable funding strategies as the country navigates reduced international support.
Stay informed and ahead of the curve! Follow The National Concord Blog Newsletter for real-time updates, breaking news, and exclusive content. Don't miss a headline – join now below!
